Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Clinical trial NCT01895842 · COMPLETED
Trial details
- NCT number
- NCT01895842
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2019-04-02
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.